AVITA Medical, Inc. Deferred Tax Assets, Valuation Allowance
AVITA Medical, Inc. (AVHHL) had Deferred Tax Assets, Valuation Allowance of $73.25 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-02-12
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $73.25M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $60.37M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $63.31M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $56.51M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $73.25M 10-K · filed 2026-02-12 | |
| 2024-12-31 | $60.37M 10-K · filed 2026-02-12 | |
| 2023-12-31 | $63.31M 10-K · filed 2025-02-13 | |
| 2022-12-31 | $56.51M 10-K · filed 2024-02-22 | |
| 2021-12-31 | $51.30M 10-Q · filed 2023-05-11 | $51.28M 10-KT · filed 2022-02-28 |
| 2021-06-30 | $49.08M 10-K · filed 2023-02-23 | |
| 2020-12-31 | $46.90M 10-Q · filed 2022-11-10 | $46.89M 10-KT · filed 2022-02-28 |
| 2020-06-30 | $41.90M 10-KT · filed 2022-02-28 | |
| 2019-06-30 | $25.94M 10-K · filed 2020-08-27 |